![Mark Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Johnson currently works at Prothena Corp.
Plc, as SVP & Head-Investor Relations.
Mr. Johnson also formerly worked at MediciNova, Inc., as Director-Investor Relations & Development, aTyr Pharma, Inc., as Senior Director-Investor Relations, and ACADIA Pharmaceuticals, Inc., as Vice President-Investor Relations.
Postes actifs de Mark Johnson
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Investor Relations Contact | 01/07/2023 |
Anciens postes connus de Mark Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| ATYR PHARMA, INC. | Investor Relations Contact | - |
| ACADIA PHARMACEUTICALS INC. | Investor Relations Contact | - |
| MEDICINOVA, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
MediciNova, Inc.
 MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Choisissez Zonebourse 
